Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort
Authors
Keywords
2-h glucose, Fasting glucose, HbA<sub>1c</sub>, Insulin resistance, Insulin sensitivity, Statin, Type 2 diabetes
Journal
DIABETOLOGIA
Volume 58, Issue 5, Pages 1109-1117
Publisher
Springer Nature
Online
2015-03-10
DOI
10.1007/s00125-015-3528-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Statins on Fasting Plasma Glucose in Diabetic and Nondiabetic Patients
- (2016) Rishi Sukhija et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus
- (2013) Eliano Pio Navarese et al. AMERICAN JOURNAL OF CARDIOLOGY
- Risk of incident diabetes among patients treated with statins: population based study
- (2013) A. A. Carter et al. BMJ-British Medical Journal
- Statin Use and Risk of Diabetes Mellitus in Postmenopausal Women in the Women's Health Initiative
- (2012) Annie L. Culver ARCHIVES OF INTERNAL MEDICINE
- Statins are diabetogenic – Myth or reality?
- (2012) Naveed Sattar et al. ATHEROSCLEROSIS SUPPLEMENTS
- Statins and risk of treated incident diabetes in a primary care population
- (2012) Nur Lisa Zaharan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Statins, Risk of Diabetes, and Implications on Outcomes in the General Population
- (2012) Kang-Ling Wang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Do statins interfere with lifestyle intervention in the prevention of diabetes in primary healthcare? One-year follow-up of the FIN-D2D project
- (2012) Nina Rautio et al. BMJ Open
- Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance
- (2011) E. Moutzouri et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy
- (2011) David Preiss JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin
- (2011) David D. Waters et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes
- (2009) Alfonso Bellia et al. ATHEROSCLEROSIS
- Changes in Insulin Sensitivity and Insulin Release in Relation to Glycemia and Glucose Tolerance in 6,414 Finnish Men
- (2009) A. Stancakova et al. DIABETES
- Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
- (2009) S. N. Rajpathak et al. DIABETES CARE
- Differing effect of statins on insulin sensitivity in non-diabetics: A systematic review and meta-analysis
- (2009) William L. Baker et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effects of High-Dose Simvastatin Therapy on Glucose Metabolism and Ectopic Lipid Deposition in Nonobese Type 2 Diabetic Patients
- (2008) J. Szendroedi et al. DIABETES CARE
- Statins and diabetes – Authors' reply
- (2008) Patricia M Kearney et al. LANCET
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started